No differences in baseline CTX or bsAUC for CTX were observed between GLP-2 infusion and placebo infusion during hypoglycemia, euglycemia, or hyperglycemia (Fig. 3A-3C, Table 3). The gene discussed is GCG; the disease is Hypoglycemia.